2015
DOI: 10.1002/ange.201510597
|View full text |Cite
|
Sign up to set email alerts
|

Degradable Molybdenum Oxide Nanosheets with Rapid Clearance and Efficient Tumor Homing Capabilities as a Therapeutic Nanoplatform

Abstract: Molybdenum oxide (MoOx) nanosheets with high near-infrared (NIR) absorbance and pH-dependent oxidative degradation properties were synthesized, functionalizedw ith polyethylene glycol (PEG), and then used as ad egradable photothermal agent and drug carrier.T he nanosheets,w hich are relatively stable under acidic pH, could be degraded at physiological pH. Therefore,M oOx-PEG distributed in organs upon intravenous injection would be rapidly degraded and excreted without apparent in vivo toxicity.M oOx-PEG shows… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
28
0

Year Published

2016
2016
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 31 publications
(29 citation statements)
references
References 29 publications
1
28
0
Order By: Relevance
“…Owing to the excellent NIR optical performance, nanomaterials such as metallic nanostructures, metal-based semiconductor nanoparticles and carbon nanomaterials have been explored and employed as PTT agents or drug release systems in in vivo cancer therapy 6 7 8 9 10 11 12 13 14 15 . Nanomaterials with a size range between 20 and 200 nm circumvent rapid renal filtration enabling passive accumulation in tumours at high concentrations for a longer time than organic molecules via the enhanced permeability and retention (EPR) effect that can hardly be achieved by other molecular agents 16 17 18 19 . However, unlike other small biodegradable molecules, inorganic nanoparticles generally have poor biodegradability and stay in the body for a long period of time accentuating the risk of deleterious effects.…”
mentioning
confidence: 99%
“…Owing to the excellent NIR optical performance, nanomaterials such as metallic nanostructures, metal-based semiconductor nanoparticles and carbon nanomaterials have been explored and employed as PTT agents or drug release systems in in vivo cancer therapy 6 7 8 9 10 11 12 13 14 15 . Nanomaterials with a size range between 20 and 200 nm circumvent rapid renal filtration enabling passive accumulation in tumours at high concentrations for a longer time than organic molecules via the enhanced permeability and retention (EPR) effect that can hardly be achieved by other molecular agents 16 17 18 19 . However, unlike other small biodegradable molecules, inorganic nanoparticles generally have poor biodegradability and stay in the body for a long period of time accentuating the risk of deleterious effects.…”
mentioning
confidence: 99%
“…168 In this study, MoO x nanosheets functionalized with PEG were prepared by a one-pot hydrothermal method and investigated for their capabilities as a photothermal therapeutic agent. The resulting MoO x nanosheets, while stable in acidic pH, degrade quickly at physiological pH.…”
Section: D Materials Hazard Assessmentmentioning
confidence: 99%
“…Nanomaterials-based drug delivery systems have attracted a great deal of attention in treatment of cancer because nanoparticle-based nanomedicines may have improved solubility, [1][2][3] reduced non-specificity toxicity, [4][5][6] altered pharmacokinetics 7,8 and bio-distributions 9,10 compared with small-molecule drugs. The future success of nanoparticle-based nanomedicine requires nanoparticles with indispensable well-defined requirements, including high biocompatibility and drug loading efficiency, [11][12][13][14][15][16] smart and controllable release, [17][18][19][20] especially the enhanced nanobio interactions for long blood circulation, [21][22][23][24] efficient tumor accumulation, and cellular uptaking, [25][26][27][28][29] etc.…”
Section: Introductionmentioning
confidence: 99%